Compare Amphastar Pharmaceuticals Inc (AMPH) vs Clorox Co (CLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Clorox Co — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.44 (market cap $826.08M), while Clorox Co trades at $94.31 (market cap $11.68B). The key difference: Clorox Co is far larger — about 14.1× Amphastar Pharmaceuticals Inc's market cap, and Clorox Co pays a 5.14% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | CLX | |
|---|---|---|
Market Cap | $826.08M | $11.68B |
Sector | Health | Consumer Staples |
52-Week High | $30.81 | $131.43 |
52-Week Low | $16.87 | $86.12 |
Enterprise Value | $1.22B | $14.98B |
Dividend Yield | — | 5.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Clorox (CLX) trades at $96.56, up 3.75% today, but remains down over 7% YTD amid declining sales and profitability concerns. The stock shows a bearish technical trend with key support at $91, while fundamentals reveal strong profitability with an 11.18% net margin and a 5.5% dividend yield. Recent corporate actions include a simplified operating structure and CEO transition, with Q2 2026 earnings pending.
The outlook is mixed: a high dividend and recent earnings beats offer value, but bearish analyst sentiment and sales declines pose risks. Upside exists if restructuring drives growth, yet investor caution is warranted given valuation premiums and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Clorox Co
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →
